Please login to the form below

Not currently logged in
Email:
Password:

ERT

This page shows the latest ERT news and features for those working in and with pharma, biotech and healthcare.

Trial dents confidence in Sangamo’s gene-editing tech

Trial dents confidence in Sangamo’s gene-editing tech

Patients in the study are still being treated with Shire’s Elaprase (idursulfase), a recombinant form of IDS used as enzyme replacement therapy (ERT) in MPS II, and Macrae said: “we ... will need to wait and see how the high-dose cohort fares when

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics